{
  "id": 4834540,
  "title": "Antifungal therapy improves microbiome dynamics in inflammatory bowel disease",
  "url": "https://urgent.news/2026/09/01/antifungal-therapy-improves-microbiome-dynamics-in-inflammatory-bowel",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-01T00:00:00.000Z",
  "source": {
    "name": "Nature Medicine",
    "slug": "nature-medicine",
    "url": "https://www.nature.com/articles/s41591-026-04616-y"
  },
  "original_language": "en",
  "account": null,
  "summary": "Nature Medicine, Published online: 01 September 2026; doi:10.1038/s41591-026-04616-y In an prospective observational study of patients with inflammatory bowel disease with oral thrush, the treatment of fluconazole (orogastrointestinal therapy), but not nystatin (oral therapy), led to intestinal mycobiome and microbiome alterations and improved disease activity at 8 weeks of follow-up.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}